Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
AdAlta Ltd
1ADCurrent price
0.018 AUD
0 AUD (0.00%)
Last closed
0.018 AUD
Company
www.adalta.com.au
ISIN
AU0000001AD2
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
10 843 312 AUD
Yield for 12 month
-10.00 %
1Y
3Y
5Y
10Y
15Y
1AD
AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia. Its lead product is AD-214, which is in Phase II clinical trial for the treatment of fibrosis diseases, including idiopathic pulmonary fibrosis, eye fibrosis, and fibrosis diseases of the liver, skin and kidney, as well as for the treatment of age-related macular degeneration. AdAlta Limited has collaborative partnerships with GE Healthcare Technologies Inc to develop i-body enabled PET imaging agents for use in immuno-oncology; and Carina Biotech Pty Ltd to develop CAR-T cell therapies for solid tumor. The company was incorporated in 2006 and is based in Bundoora, Australia. Address: La Trobe Institute of Molecular Science, Bundoora, VIC, Australia, 3086
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
+1 726 905 AUD
Last Year
+3 447 433 AUD
Current Quarter
+594 186 AUD
Last Quarter
+1 132 719 AUD
Current Year
+1 498 464 AUD
Last Year
+3 417 699 AUD
Current Quarter
+482 444 AUD
Last Quarter
+1 122 804 AUD
Key Figures 1AD
1 year
3 years
5 years
10 years
EBITDA
-5 269 464 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-50.02 %
PEG Ratio
–
Return On Equity TTM
-273.13 %
Wall Street Target Price
–
Revenue TTM
1 726 905 AUD
Book Value
0.003 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-74.7 %
Dividend Yield
–
Gross Profit TTM
2 975 637 AUD
Earnings per share
-0.0099 AUD
Diluted Eps TTM
-0.0099 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 1AD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 1AD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 1AD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
5.5008
Price Sales TTM
6.279
Enterprise Value EBITDA
-1.0634
Price Book MRQ
5.9089
Financials 1AD
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 1AD
For 52 weeks
0.016 AUD
0.041 AUD
50 Day MA
0.019 AUD
Shares Short Prior Month
–
200 Day MA
0.023 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart